Deborah Riney
Psychiatric/Mental Health · Dallas, TXNPI 1386653764
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 305 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $2,914 and has fallen 99.4% since, to $17 in 2024. Among psychiatric/mental health clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 305 payments — averaging $21.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$920
- AbbVie$880
- Alkermes, Inc.$788
- Neurocrine Biosciences, Inc.$719
- Lundbeck LLC$392
- Johnson & Johnson$383
- plus $3K from 24 others
What the payments were for
- Food & beverage$6,637100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 29 | $920 |
| AbbVie | 59 | $880 |
| Alkermes, Inc. | 32 | $788 |
| Neurocrine Biosciences, Inc. | 22 | $719 |
| Lundbeck LLC | 19 | $392 |
| Johnson & Johnson | 18 | $383 |
| Otsuka America Pharmaceutical, Inc. | 19 | $374 |
| Neuronetics, Inc. | 2 | $273 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $195 |
| Merck | 11 | $185 |
| Neos Therapeutics, LP | 8 | $164 |
| Sunovion Pharmaceuticals Inc. | 8 | $153 |
| Bausch Health US, LLC | 15 | $140 |
| Teva Pharmaceuticals USA, Inc. | 6 | $139 |
| Vanda Pharmaceuticals Inc. | 6 | $127 |
| Supernus Pharmaceuticals, Inc. | 7 | $98 |
| Noven Pharmaceuticals, Inc. | 1 | $96 |
| Noven Therapeutics, LLC | 4 | $78 |
| Tris Pharma Inc | 4 | $74 |
| Eisai Inc. | 4 | $71 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| Ironshore Pharmaceuticals Inc. | 3 | $62 |
| Alfasigma USA, Inc. | 3 | $48 |
| Avanir Pharmaceuticals, Inc. | 3 | $47 |
| Corium, LLC | 3 | $47 |
| Jazz Pharmaceuticals Inc. | 1 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Almatica Pharma LLC | 1 | $21 |
| Orexo US, Inc. | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,637 in reported general payments places this provider in the 90th percentile of 2,724 psychiatric/mental health providers in Texas.
Other psychiatric/mental health in Dallas
- Kimberly ThompsonDallas$25K
- Melissa RiveraDallas$19K
- Jillian AdamsDallas$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
- Monique GonzalezSan Antonio$126K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.